A comparative study of 511 keV SPECT and PET using separate 370 MBq F-18-FDG doses on different days

Clinical Positron Imaging (Netherlands)

Volumn 2, Issue 2, 1999, Pages 81-91

  Lamonica, Dominick ^a,b   Grossman, Zachary ^a   Klippenstein, Donald ^a   Wang, Henry ^a   Vilani, Joseph ^a   Nabi, Hani Abdel ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Fluorine 18 fluorodeoxyglucose (FDG); Nuclear Oncology; Positron Emission Tomography (PET); Positron Imaging; Single photon Emission Computed Tomography (SPECT); Tomography

Indexed keywords

EID: 8444246761     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(99)00007-2     Document Type: Article

References (17)

1. Freiherr, G. Global acceptance of PET increasing. In: Positron Imaging 1997. Siemens Corp., (4 pg. Brochure, no A91004-M2300-M054-01-7600); 1–4; 1977.
2. W. Drane F. Abbott M. Nicole S. Mastin J. Kuperus Technology for FDG SPECT with a relatively inexpensive gamma camera Radiology 191 1994 462 465
3. D.J. Macfarlane L. Cotton R.J. Ackerman Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy- d -glucose (FDG) initial evaluation in oncology and comparison with FDG PET Radiology 194 1995 425 429
4. W.H. Martin D. Delbeke J.A. Patton M.P. Sandler Detection of malignancies with SPECT versus PET, with 2-[flourine-18]fluoro-2-deoxy- d -glucose Radiology 198 1996 225 231
5. W.H. Martin D. Delbeke J.A. Patton FDG-SPECT correlation with FDG-PET J. Nucl. Med. 36 1995 988 995
6. H. Minn H. Joensuu A. Ahonen Fluorodeoxyglucose imaging a method to assess the proliferative activity of human cancer in vivo—comparison DNA flow cytometry in head and neck tumors Cancer 61 1988 1776 1781
7. D. Delbeke J.V. Vitrola M.P. Sandler Staging recurrent metastatic colorectal carcinoma with PET J. Nucl. Med. 38 1977 1196 1201
8. M. Lapela R. Grenman T. Kurki Head and neck cancer detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy- d -glucose Radiology 197 1995 205 211
9. R.L. Wahl L.E. Quint R.L. Greenough C.R. Meyer R.I. White M.B. Orringer Staging of mediastinal non-small cell lung cancer with FDG PET, CT and fusion imaging preliminary prospective evaluation Radiology 191 1994 371 377
10. S.K. Mukherji W.E. Drane A.A. Mancuso J.T. Parsons W.M. Mendenhall S. Stinger Occult primary tumors of the head and neck detection with 2-(F-18) fluoro-2-deoxy- d -glucose SPECT Radiology 199 1996 761 766
11. V. Cronin P. Galantowicz H. Nabi Development of oncology protocol using fluorine-18-FDG one center’s experience J. Nucl. Med. Technol. 25 1997 66 69
12. S.K. Singh K.F. Hubner E. Buonocore G.T. Smith H.R. Gould Comparison of FDG PET, and CT in staging lung cancer preliminary findings K.F. Hubner J. Collmann E. Buonocore G.W. Kabalka Clinical positron emission tomography, 1st. ed 1992 Mosby-Yearbook, Inc St. Louis 73 77
13. L.H. Holle L. Trampert S. Lung-Kurt Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT J. Nucl. Med. 37 1996 615 622
14. R. Burt O. Perkins B. Oppenheim Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability J. Nucl. Med. 26 1995 176 179
15. E. Chen W. MacIntyre R. Go Myocardial viability studies using fluorine-18-FDG SPECT a comparison with fluorine-18-FDG PET J. Nucl. Med. 38 1997 582 586
16. N. Gupta A. Frank N. Dewan Solitary pulmonary nodules detection of malignancy with PET with 2-(F-18)-fluoro-2-deoxyglucose- d -glucose Radiology 184 1992 441 444
17. V. Lowe D. Hoffman D. Delong E. Patz Jr. R. Coleman Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities J. Nucl. Med. 35 1994 1771 1776